EMCDDA Home
  • EN
Search

Table GPS-12. Last month prevalence (percentage) of drug use among all adults (aged 15 to 64 years old) in nationwide surveys among the general population: last survey available for each Member State

CountryGeographical areaYearRef.Age range all adultsSample size all adultsCannabis (%)Cocaine (%) 1a)Amphet-amines (%) (2)Ecstasy (%) (3)LSD (%)
BelgiumNational2004(6)15-643.0
BulgariaNational2005(1)18-6010360.80.20.20.50.2
Czech RepublicNational2004(2)18-6435264.80.00.21.10.1
DenmarkNational2005(4)16-64133102.60.30.30.10.0
GermanyNational2003(6)18-5980613.40.40.40.20.1
EstoniaNational2003(2)15-641.40.00.30.40.0
IrelandNational2002-03(4)15-6449182.60.30.20.30.0
GreeceNational (except Aegean and Ionian Islands)2004(3)15-6443510.90.00.00.00.0
SpainNational2005-06(6)15-64279348.71.60.40.6
FranceNational2005(6)15-64258794.80.20.10.10.0
ItalyNational2005(3)15-64279955.80.80.20.20.2
CyprusNational2006(1)15-6435041.40.40.30.60.3
LatviaNational2003(1)15-6445341.80.10.50.30.3
LithuaniaNational2004(1)15-6442070.70.10.10.20.0
LuxembourgNational1998(1)15-644.00.20.00.0
HungaryNational2003(2)18-541.40.20.40.40.2
MaltaNational2001(1)18-6417550.50.10.00.20.0
NetherlandsNational2005(3)15-6445163.30.30.20.40.0
AustriaNational2004(1)15-6439803.80.40.40.40.1
PolandNational2002(1)16-641.30.10.20.20.0
PortugalNational2001(1)15-64141862.40.10.10.20.0
RomaniaNational2004(1)15-64
SlovakiaNational2004(2)15-6413151.70.10.00.4
FinlandNational2004(6)15-6423521.60.00.20.20.1
SwedenNational2006(7)16-64417010.6
United KingdomEngland and Wales2005-06(9)16-59297485.21.20.60.70.1
United KingdomNorthern Ireland2002-03(10)15-6435162.90.10.20.50.0
United KingdomScotland2004(12)16-6432933.00.40.40.30.1
United KingdomUnited Kingdom2004(13)6.21.00.50.90.1
NorwayNational2004(2)15-6426692.20.30.20.10.0

Notes:

 (1) Cocaine any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy. 

 (3) For Spain: ecstasy and other synthetic drugs. 

 This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.    

 In surveys with small sample sizes results should be interpreted with caution.   

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.    

 For methods and definitions see General population surveys of drug use – methods and definitions.   

 See also 'General notes for interpreting data' on the Explanatory notes and help page.   

Sources:

 See Table GPS-0.              

Page last updated: Wednesday, 07 November 2007